iota Biosciences
AcquiredBerkeley, US · Founded 2017 · Delaware corporation · 1 known investors
Find your way into iota Biosciences
Acquired by Astellas Pharma October 2020 · $127.5M ($127.5M upfront plus up to $176.5M in milestone payments) · source ↗
Iota Biosciences was a UC Berkeley spinout that developed ultrasound-powered, millimeter-scale implantable "neural dust" devices to wirelessly monitor and stimulate nerves and organs for treating chronic diseases.
Founders & leadership
iota Biosciences was founded in 2017 by Michel Maharbiz and Jose Carmena.
MM
Michel MaharbizCo-founder
JC
Jose CarmenaCo-founder
PZ
Patrick ZhangNamed on SEC filing
Investors · 1
Reported raises · per SEC filings
Form D private placements$15M disclosed across 1 round · 2018
▶$15MraisedMay 2018 · 17 investors · Other TechnologyRule 506(b)
▶$15MraisedMay 2018 · 17 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Michel MaharbizExecutive Officer, Director
- Jose CarmenaExecutive Officer, Director
- Patrick ZhangDirector
- Offering amount
- $15M
- Amount sold
- $15M
- First sale
- May 2018
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does iota Biosciences do?
- Iota Biosciences was a UC Berkeley spinout that developed ultrasound-powered, millimeter-scale implantable "neural dust" devices to wirelessly monitor and stimulate nerves and organs for treating chronic diseases.
- Who founded iota Biosciences?
- iota Biosciences was founded by Michel Maharbiz, Jose Carmena in 2017.
- Who are iota Biosciences's investors?
- iota Biosciences's investors include Bold Capital Partners.
- How much funding has iota Biosciences raised?
- iota Biosciences has disclosed $15M raised across 1 round.
- Where is iota Biosciences headquartered?
- iota Biosciences is headquartered in Berkeley, US.